Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826667 · ClinicalTrials.gov registry record
PMCF Study on PEEK Suture Anchors for Shoulder Indications
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 464
- Enrollment target
NCT03826667: Completed study, sponsored by Smith & Nephew.
NCT03826667 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 464 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03826667 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 464 participants
- Enrollment target
Study Summary
Post-market clinical follow-up on the PEEK Suture Anchors in the shoulder.
Primary Outcome
Clinical success was defined as shoulder repairs without signs of device failure and/or re-intervention as assessed by the surgeon. Specifically, clinical success was considered "Yes" based on the following 3 main criteria: * no inflammatory or allergic response * no device-related adverse event (AE) * no device deficiencies (DDs) leading to revision surgery (re intervention) on the index shoulder
Interventions
- DEVICE Polyetheretherketone (PEEK) Shoulder Suture Anchors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 464 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2019-08-28 |
What the finished NCT03826667 record still lists
NCT03826667 is an observational study that tracks outcomes without assigning an intervention. The registered 464 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Polyetheretherketone (PEEK) Shoulder Suture Anchors is the first listed.
NCT03826667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03826667 about?
NCT03826667 is a clinical study titled "PMCF Study on PEEK Suture Anchors for Shoulder Indications". Post-market clinical follow-up on the PEEK Suture Anchors in the shoulder.
What is the current status of trial NCT03826667?
This trial is currently completed. The enrollment target is 464 participants. The study started on 2019-02-14. Estimated completion is 2019-08-28.
What interventions are being tested in trial NCT03826667?
The interventions under investigation include: Polyetheretherketone (PEEK) Shoulder Suture Anchors (DEVICE).
Who is sponsoring clinical trial NCT03826667?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI